Franklin Resources Inc Biotechnology

Franklin Resources Inc

$356 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
TECH Bio Techne Corp	$2.45B	$606,000 0.0% of portfolio	11,796	Q2 2025 Reduced 34.77%
EWTX Edgewise Therapeutics, Inc.	$1.16B	$600,000 0.0% of portfolio	45,806	Q2 2025 Reduced 1.04%
MNKD Mannkind Corp	$1.43B	$598,000 0.0% of portfolio	160,016	Q3 2024 Added 2.96%
VERV Verve Therapeutics, Inc.	$667M	$536,000 0.0% of portfolio	47,783	Q2 2025 Added 40.04%
CRMD Cor Medix Inc.	$467M	$497,000 0.0% of portfolio	40,420	Q2 2025 Added 4.44%
SWTX Spring Works Therapeutics, Inc.	$2.93B	$483,000 0.0% of portfolio	10,288	Q2 2025 Reduced 93.78%
XERS Xeris Biopharma Holdings, Inc.	$1.33B	$482,000 0.0% of portfolio	103,278	Q2 2025 Reduced 4.32%
RXRX Recursion Pharmaceuticals, Inc.	$1.02B	$422,000 0.0% of portfolio	83,461	Q2 2025 Added 0.18%
FULC Fulcrum Therapeutics, Inc.	$460M	$412,000 0.0% of portfolio	60,022	Q2 2025 Added 141.82%
WVE Wave Life Sciences Ltd.	$765M	$402,000 0.0% of portfolio	61,982	Q2 2025 Added 36.18%
ETNB 89bio, Inc.	$690M	$399,000 0.0% of portfolio	40,651	Q2 2025 New
TBPH Theravance Biopharma, Inc.	$955M	$394,000 0.0% of portfolio	35,809	Q2 2025 Added 0.03%
GLUE Monte Rosa Therapeutics, Inc.	$608M	$381,000 0.0% of portfolio	84,488	Q2 2025 Added 213.51%
CRSP Crispr Therapeutics Ag	$4.99B	$369,000 0.0% of portfolio	7,600	Q2 2025 Added 2.22%
CDXC Chroma Dex Corp.	$420M	$351,000 0.0% of portfolio	57,309	Q2 2025 Added 9.27%
XNCR Xencor Inc	$844M	$351,000 0.0% of portfolio	44,683	Q2 2025 Added 5.44%
ARDX Ardelyx, Inc.	$931M	$341,000 0.0% of portfolio	87,114	Q2 2025 Reduced 16.4%
PRTA Prothena Corp Public LTD CO	$504M	$340,000 0.0% of portfolio	56,078	Q2 2025 Added 183.98%
BEAM Beam Therapeutics Inc.	$1.76B	$324,000 0.0% of portfolio	19,098	Q2 2025 Reduced 7.17%
ABUS Arbutus Biopharma Corp	$726M	$322,000 0.0% of portfolio	104,423	Q2 2025 Added 12.96%
TRVI Trevi Therapeutics, Inc.	$672M	$273,000 0.0% of portfolio	49,918	Q2 2025 Added 33.93%
SANA Sana Biotechnology, Inc.	$932M	$254,000 0.0% of portfolio	93,081	Q2 2025 Added 86.78%
TSHA Taysha Gene Therapies, Inc.	$242M	$250,000 0.0% of portfolio	108,399	Q2 2025 Reduced 6.74%
RGNX Regenxbio Inc.	$554M	$238,000 0.0% of portfolio	29,101	Q2 2025 New
IBRX Immunity Bio, Inc.	$945M	$230,000 0.0% of portfolio	87,141	Q2 2025 New
IONS Ionis Pharmaceuticals Inc	$10.5B	$219,000 0.0% of portfolio	5,556	Q2 2025 New
MGTX Meira G Tx Holdings PLC	$408M	$211,000 0.0% of portfolio	32,514	Q2 2025 Reduced 0.1%
FOLD Amicus Therapeutics, Inc.	$2.53B	$200,000 0.0% of portfolio	34,995	Q2 2025 Added 39.05%
ERAS Erasca, Inc.	$300M	$155,000 0.0% of portfolio	122,128	Q2 2025 Added 4.13%
FENC Fennec Pharmaceuticals Inc.	$214M	$135,000 0.0% of portfolio	16,384	Q2 2025 Added 2.48%
PBYI Puma Biotechnology, Inc.	$233M	$60,000 0.0% of portfolio	17,691	Q2 2025 Reduced 77.37%
CGEN Compugen LTD	$146M	$56,000 0.0% of portfolio	31,726	Q2 2025 New
ONCY Oncolytics Biotech Inc	$68.3M	$48,000 0.0% of portfolio	63,275	Q1 2025 Added 399.57%
PGEN Precigen, Inc.	$847M	$47,000 0.0% of portfolio	33,435	Q2 2025 Reduced 0.49%
MRVI Maravai Lifesciences Holdings, Inc.	$413M	$32,000 0.0% of portfolio	13,571	Q2 2025 Reduced 81.11%
FATE Fate Therapeutics Inc	$131M	$11,000 0.0% of portfolio	10,197	Q1 2025 Reduced 93.83%
SGMO Sangamo Therapeutics, Inc	$89.2M	$8,000 0.0% of portfolio	16,594	Q1 2025 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	1,828,755	Q2 2025 Reduced 1.55%
NUVB Nuvation Bio Inc.	$1.12B	$0 0.0% of portfolio	210	Q2 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.